Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2025 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals gibt ein Update zur Lizenzvereinbarung für AGAMREE® (Vamorolon) und den von Idorsia gehaltenen Warrants

Pratteln, Schweiz, 16. Januar 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass Idorsia Pharmaceuticals eine Lizenz-Monetarisierungsvereinbarung mit dem R-Bridge Healthcare Fund im...
January 16, 2025 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia

Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that Idorsia Pharmaceuticals has entered into a royalty monetization agreement with the R-Bridge Healthcare...